# Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors

> **NCT00756847** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 52 (actual)

## Conditions studied

- Cancer
- Non-Small Cell Lung Cancer
- Endometrial Carcinoma
- Ovarian Carcinoma

## Interventions

- **DRUG:** XL147 (SAR245408),
- **DRUG:** paclitaxel
- **DRUG:** carboplatin

## Key facts

- **NCT ID:** NCT00756847
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756847, "Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00756847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*